Literature DB >> 17943064

Temporal lobe epilepsy: a progressive disorder?

Katherine Nearing1, Deepak Madhavan, Orrin Devinsky.   

Abstract

Temporal lobe epilepsy (TLE) can be a progressive disorder, potentially resulting in structural damage and a decline of cognitive abilities over time. This is particularly evident in cases that are refractory to medication. This review examines the changes that occur in refractory TLE over time and the factors associated with these changes. Imaging and histologic studies on the brains of patients with TLE reveal anatomic and metabolic changes associated with continued seizures. These changes can impair cognitive and behavioral function. Seizure control may help minimize or prevent these changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943064

Source DB:  PubMed          Journal:  Rev Neurol Dis        ISSN: 1545-2913


  10 in total

1.  The window of epileptogenesis: looking beyond the latent period.

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2009 Sep-Oct       Impact factor: 7.500

2.  Convulsive status epilepticus duration as determinant for epileptogenesis and interictal discharge generation in the rat limbic system.

Authors:  Aleksandra Bortel; Maxime Lévesque; Giuseppe Biagini; Jean Gotman; Massimo Avoli
Journal:  Neurobiol Dis       Date:  2010-08-01       Impact factor: 5.996

3.  Suppression of adult neurogenesis increases the acute effects of kainic acid.

Authors:  Sloka S Iyengar; John J LaFrancois; Daniel Friedman; Liam J Drew; Christine A Denny; Nesha S Burghardt; Melody V Wu; Jenny Hsieh; René Hen; Helen E Scharfman
Journal:  Exp Neurol       Date:  2014-12-02       Impact factor: 5.330

Review 4.  Temporal lobe surgery and memory: Lessons, risks, and opportunities.

Authors:  Kristie Bauman; Orrin Devinsky; Anli A Liu
Journal:  Epilepsy Behav       Date:  2019-11-09       Impact factor: 2.937

5.  Executive functions in chronic mesial temporal lobe epilepsy.

Authors:  Laura Zamarian; Eugen Trinka; Elisabeth Bonatti; Giorgi Kuchukhidze; Thomas Bodner; Thomas Benke; Florian Koppelstaetter; Margarete Delazer
Journal:  Epilepsy Res Treat       Date:  2011-03-06

6.  Intranasal Delivery of miR-146a Mimics Delayed Seizure Onset in the Lithium-Pilocarpine Mouse Model.

Authors:  Hua Tao; Jianghao Zhao; Tingting Liu; Yujie Cai; Xu Zhou; Huaijie Xing; Yan Wang; Mingkang Yin; Wangtao Zhong; Zhou Liu; Keshen Li; Bin Zhao; Haihong Zhou; Lili Cui
Journal:  Mediators Inflamm       Date:  2017-01-24       Impact factor: 4.711

7.  Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders.

Authors:  Luisa Rocha; Resat Cinar; Rosalinda Guevara-Guzmán; Mario Alonso-Vanegas; Daniel San-Juan; Iris Martínez-Juárez; José Luis Castañeda-Cabral; Francia Carmona-Cruz
Journal:  Front Behav Neurosci       Date:  2020-05-06       Impact factor: 3.558

8.  Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus.

Authors:  Tobias Engel; Raquel Gómez-Sintes; Mariana Alves; Eva M Jimenez-Mateos; Marta Fernández-Nogales; Amaya Sanz-Rodriguez; James Morgan; Edward Beamer; Alberto Rodríguez-Matellán; Mark Dunleavy; Takanori Sano; Jesus Avila; Miguel Medina; Felix Hernandez; José J Lucas; David C Henshall
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

9.  Elevated Blood C-Reactive Protein Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis.

Authors:  Rui Zhong; Qingling Chen; Mengmeng Li; Xinyue Zhang; Weihong Lin
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

10.  Investigating the molecular mechanism of Compound Danshen Dropping Pills for the treatment of epilepsy by utilizing network pharmacology and molecular docking technology.

Authors:  Dan Huang; Xiaolong Wen; Chuansen Lu; Bo Zhang; Zongjun Fu; Yingliu Huang; Kun Niu; Fan Yang
Journal:  Ann Transl Med       Date:  2022-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.